URMC »Research » Research@URMC Blog » October 2013

October 2013

Testicular Cancer: A Good News/Bad News Story

First, the good news: The survival rate for testicular cancer is 95 percent at 10 years, due to the invention of cisplatin-based chemotherapy in the 1970s. Despite this success, however, survivors have an increasing risk of second malignancies -- and the risk remains elevated for 35 years.

10/9/2013 | 0 comments

Stomach Flu Vaccine Looks Good in Early Trial

A new vaccine for norovirus – the microbe behind most cases of what people commonly call stomach flu – protected patients against severe vomiting and diarrhea. URMC was one of five study sites that enrolled patients and tested the experimental vaccine. 

10/8/2013 | 0 comments

Secret to Longevity: Naked Mole Rats?

Those fascinating creatures are in the news again. In a study published in June researchers found a key to their cancer resistance. This week, University of Rochester biologists showed that the rodent’s longevity – they live a healthy 30 years, which is very long in rat years – is due to better-constructed proteins.

10/1/2013 | 0 comments
12